Status:
COMPLETED
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Lead Sponsor:
Wake Forest University
Conditions:
Actinic Keratosis
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.
Detailed Description
The purpose of this research study is to measure adherence to the study drug for the treatment of actinic keratoses. The study drug is 5-Fluorouracil (Carac®); it will be used in this study to treat a...
Eligibility Criteria
Inclusion
- Any male or female 50 years of age or older with moderate to severe actinic keratoses of the face and anterior scalp diagnosed by a dermatologist will be eligible for participation.
Exclusion
- Age less than 50.
- Known allergy or sensitivity to topical Carac® in the subject.
- Inability to complete all study-related visits.
- Introduction of any other prescription medication, topical or systemic, for actinic keratosis while participating in the study.
- Subjects should not receive surgical or cryotherapy while participating in the study.
- Pregnant women, women who are breast feeding, or women of child bearing potential who are not practicing two acceptable methods of birth control
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00696488
Start Date
April 1 2007
End Date
October 1 2008
Last Update
September 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences Dermatology
Winston-Salem, North Carolina, United States, 27157